Cellectra™ Human CD19 NanoDeplet Microbeads, Research grade

Cellectra™ Human CD19 NanoDeplet Microbeads, Research grade are dextran-coated superparamagnetic iron oxide nanoparticles of which the surface is conjugated with recombinant monoclonal antibodies specific to human CD19 (Isotype: mouse IgG1). They are especially designed for the depletion of CD19+ cells.
Cellectra™ Human CD19 NanoDeplet Microbeads, Research grade are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

Cellectra™ Human CD19 NanoDeplet Microbeads, Research grade are designed for the depletion of CD19⁺ B cells from fresh or frozen human peripheral blood mononuclear cells (PBMCs). CD19, also known as B4, is a transmembrane glycoprotein expressed on most B-lineage cells and plays a key role in B cell activation and signaling. Depletion of B cells provides a purified population of non-B cells for downstream applications, including T cell functional assays, immune cell therapy preparation (e.g., CAR-T cells), and NK cell or monocyte functional studies. The magnetic Microbeads are conjugated with monoclonal antibodies targeting human CD19 protein, enabling CD19+ cells to be labeled with the specific antibodies and magnetic particles, and separated using the separation columns and magnets.

For long term storage, the product should be stored in liquid state at-20°C or below Stability upon receipt: Stable for 24 months at-20 °C or below; Stable for 6 months at 2–8 °C under sterile conditions. Please protect from light and avoid repeated freeze-thaw cycles

Negative

Less than 2 EU per mL by the LAL method / rFC method.

Negative

This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

Supplied in PBS buffer containing EDTA, rHSA and Poloxamer 188.